Literature DB >> 15642752

Testing the theoretical design of a health risk message: reexamining the major tenets of the extended parallel process model.

Thomas D Gore1, Cheryl Campanella Bracken.   

Abstract

This study examined the fear control/danger control responses that are predicted by the Extended Parallel Process Model (EPPM). In a campaign designed to inform college students about the symptoms and dangers of meningitis, participants were given either a high-threat/no-efficacy or high-efficacy/no-threat health risk message, thus testing the extreme assumptions of the EPPM. Although the study supports the main predictions of the EPPM in the context of meningitis, the results provide new evidence that only a marginal amount of threat is necessary in a health risk message to move the target audience toward the desired protective measures. In addition, the results also suggest that the messages containing only threat may only scare the target audience further into fear control. Implications and future research are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15642752     DOI: 10.1177/1090198104266901

Source DB:  PubMed          Journal:  Health Educ Behav        ISSN: 1090-1981


  16 in total

1.  Encouraging early preventive dental visits for preschool-aged children enrolled in Medicaid: using the extended parallel process model to conduct formative research.

Authors:  Natoshia M Askelson; Donald L Chi; Elizabeth Momany; Raymond Kuthy; Cristina Ortiz; Jessica D Hanson; Peter Damiano
Journal:  J Public Health Dent       Date:  2012-09-21       Impact factor: 1.821

2.  Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing.

Authors:  Watcharaporn Pengchit; Scott T Walters; Rebecca G Simmons; Wendy Kohlmann; Randall W Burt; Marc D Schwartz; Anita Y Kinney
Journal:  J Health Psychol       Date:  2011-04-04

3.  Effectiveness of the extended parallel process model in promoting colorectal cancer screening.

Authors:  Wendy C Birmingham; Man Hung; Watcharaporn Boonyasiriwat; Wendy Kohlmann; Scott T Walters; Randall W Burt; Antoinette M Stroup; Sandie L Edwards; Marc D Schwartz; Jan T Lowery; Deirdre A Hill; Charles L Wiggins; John C Higginbotham; Philip Tang; Shirley D Hon; Jeremy D Franklin; Sally Vernon; Anita Y Kinney
Journal:  Psychooncology       Date:  2015-07-20       Impact factor: 3.894

4.  Reconceptualizing efficacy in substance use prevention research: refusal response efficacy and drug resistance self-efficacy in adolescent substance use.

Authors:  Hye Jeong Choi; Janice L Krieger; Michael L Hecht
Journal:  Health Commun       Date:  2013

5.  Masculinity and intentions to perform health behaviors: the effectiveness of fear control arguments.

Authors:  Murray G Millar; Jeremy Ashton Houska
Journal:  J Behav Med       Date:  2007-05-24

6.  Reactions to tobacco warning labels: predictors and outcomes of adaptive and maladaptive responses.

Authors:  Daniel Owusu; Jiyeon So; Lucy Popova
Journal:  Addict Res Theory       Date:  2019-02-22

7.  No significant association of repeated messages with changes in health compliance in the COVID-19 pandemic: a registered report on the extended parallel process model.

Authors:  Jingwen Yang; Xue Wu; Kyoshiro Sasaki; Yuki Yamada
Journal:  PeerJ       Date:  2021-06-03       Impact factor: 2.984

8.  Social Media Use, Self-Efficacy, Perceived Threat, and Preventive Behavior in Times of COVID-19: Results of a Cross-Sectional Study in Pakistan.

Authors:  Qaisar Khalid Mahmood; Sara Rizvi Jafree; Sahifa Mukhtar; Florian Fischer
Journal:  Front Psychol       Date:  2021-06-17

9.  Exercise preferences among emerging adults: Do men and women want different things?

Authors:  Jean M Reading; Jessica Gokee LaRose
Journal:  J Am Coll Health       Date:  2020-08-19

10.  Predictors of early sexual initiation among a nationally representative sample of Nigerian adolescents.

Authors:  Adesegun O Fatusi; Robert W Blum
Journal:  BMC Public Health       Date:  2008-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.